UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000035234
Receipt number R000040147
Scientific Title Elucidation of pathomechanisms of neurodegenerative diseases by 7 Tesla MRI
Date of disclosure of the study information 2018/12/13
Last modified on 2021/12/14 11:23:18

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Elucidation of pathomechanisms of neurodegenerative diseases by 7 Tesla MRI

Acronym

Elucidation of pathomechanisms of neurodegenerative diseases by 7 Tesla MRI

Scientific Title

Elucidation of pathomechanisms of neurodegenerative diseases by 7 Tesla MRI

Scientific Title:Acronym

Elucidation of pathomechanisms of neurodegenerative diseases by 7 Tesla MRI

Region

Japan


Condition

Condition

Parkinson's disease
Alzheimer's disease
Tauopathy
Spinocerebellar degeneration
REM sleep behavior disorder

Classification by specialty

Neurology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We plan to elucidate the changes of cortical and subcortical grey matters in neurodegenerative disorders by 7T MRI.

Basic objectives2

Others

Basic objectives -Others

To elucidate the pathophysiology

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The changes detected by MRI in neurodegenerative disorders

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Device,equipment

Interventions/Control_1

Obtain images in every 2 years within 4 years.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who agreed to participate in the study.

Key exclusion criteria

Patients with poor general condition and contraindication for MRI.

Target sample size

190


Research contact person

Name of lead principal investigator

1st name Nobukatsu
Middle name
Last name Sawamoto

Organization

Kyoto University Graduate School of Medicine

Division name

Human Health Sciences

Zip code

6068507

Address

53 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto City

TEL

0757513111

Email

sawa@kuhp.kyoto-u.ac.jp


Public contact

Name of contact person

1st name Atsushi
Middle name
Last name Shima

Organization

Kyoto University Graduate School of Medicine

Division name

Human Brain Research Center

Zip code

6068507

Address

54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto City

TEL

0757513111

Homepage URL


Email

shiima@kuhp.kyoto-u.ac.jp


Sponsor or person

Institute

Kyoto University

Institute

Department

Personal name



Funding Source

Organization

Japan Agency for Medical Research and Development

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kyoto University

Address

Yoshida-konoe-cho, Sakyo-ku, Kyoto

Tel

0757513111075-753-4680

Email

ethcom@kuhp.kyoto-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 12 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2018 Year 12 Month 07 Day

Date of IRB

2018 Year 12 Month 12 Day

Anticipated trial start date

2018 Year 12 Month 24 Day

Last follow-up date

2028 Year 12 Month 11 Day

Date of closure to data entry

2028 Year 12 Month 11 Day

Date trial data considered complete

2028 Year 12 Month 11 Day

Date analysis concluded

2028 Year 12 Month 11 Day


Other

Other related information



Management information

Registered date

2018 Year 12 Month 12 Day

Last modified on

2021 Year 12 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040147


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name